NCT04139811

Brief Summary

Internal limiting membrane peeling is performed during vitrectomy for macular diseases such as macular holes, macular edema due to diabetic retinopathy and retinal vein occlusion. The incidence of epiretinal membrane formation after vitrectomy for rhegmatogenous detachment has been reported to range from 4.4% to 12.8%. In this study, the efficacy and safety of internal limiting membrane peeling will be studied in vitrectomy for rhegmatogenous retinal detachment and if it is essential to peel it in those cases or not.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 15, 2017

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 15, 2019

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 15, 2019

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

September 24, 2019

Completed
1 month until next milestone

First Posted

Study publicly available on registry

October 25, 2019

Completed
Last Updated

October 25, 2019

Status Verified

October 1, 2019

Enrollment Period

2.3 years

First QC Date

September 24, 2019

Last Update Submit

October 23, 2019

Conditions

Keywords

Internal limiting membranemultifocal electoretinogram (ERG)OCT-Angiography

Outcome Measures

Primary Outcomes (2)

  • anatomical outcome

    Rate of retinal reattachment using indirect ophthalmoscopy

    6 months follow up

  • epiretinal membrane

    incidence rate of epiretinal membrane formation after surgery in % percent

    6 months follow up

Secondary Outcomes (3)

  • functional outcome

    6 months follow up

  • superficial capillary density

    6 months follow up

  • multi-focal Electroretinogram

    6 months follow up

Study Arms (2)

non-ILM peeling group

OTHER

vitrectomy without ILM peeling is done to all cases

Other: Pars Plana Vitrectomy

ILM peeling group

OTHER

vitrectomy with ILM peeling is done to all cases

Other: Pars Plana Vitrectomy

Interventions

vitrectomy with and without ILM peeling

ILM peeling groupnon-ILM peeling group

Eligibility Criteria

Age20 Years - 73 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All eyes with recent macula-off rhegmatogenous retinal detachment (RRD).

You may not qualify if:

  • Complicated cases with advanced proliferative vitreoretinopathy (PVR).
  • Patients with retinal vascular disorders and other macular disorders.
  • Combined tractional and rhegmatogenous detachment.
  • Previous retinal reattachment surgery or Intravitreal injections.
  • Glaucomatous patients.
  • Patients with corneal opacity which impairs good visualization.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Minia UNiversity hospital

Minya, Minya Governorate, 61111, Egypt

Location

Related Publications (1)

  • Abdullah ME, Moharram HEM, Abdelhalim AS, Mourad KM, Abdelkader MF. Evaluation of primary internal limiting membrane peeling in cases with rhegmatogenous retinal detachment. Int J Retina Vitreous. 2020 May 7;6:8. doi: 10.1186/s40942-020-00213-4. eCollection 2020.

MeSH Terms

Conditions

Retinal Detachment

Condition Hierarchy (Ancestors)

Retinal DiseasesEye Diseases

Study Officials

  • Mohamed F Othman, MD

    sub-investigator

    PRINCIPAL INVESTIGATOR
  • Ahmed Shawkat, MD

    sub-investigator

    PRINCIPAL INVESTIGATOR
  • khalid Murad

    sub-investigator

    PRINCIPAL INVESTIGATOR
  • Mohamed Abdullah

    sub-investigator

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant professor of ophthalmology

Study Record Dates

First Submitted

September 24, 2019

First Posted

October 25, 2019

Study Start

March 15, 2017

Primary Completion

July 15, 2019

Study Completion

August 15, 2019

Last Updated

October 25, 2019

Record last verified: 2019-10

Data Sharing

IPD Sharing
Will not share

Locations